Crossmark

Blood phosphorylated Tau217 distinguishes amyloid-positive from amyloid-negative subjects in the Alzheimer's disease continuum. A systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s00415-025-12996-3

Published Online: 2025-03-06

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Antonioni, Annibale https://orcid.org/0000-0003-1555-6418
Raho, Emanuela Maria

Di Lorenzo, Francesco

Manzoli, Lamberto

Flacco, Maria Elena

Koch, Giacomo
Funding

Funding for this research was provided by:

Università degli Studi di Ferrara
License Information

Text and Data Mining valid from 2025-03-01

Version of Record valid from 2025-03-06
More Information

Article History

Received: 20 January 2025

Revised: 18 February 2025

Accepted: 19 February 2025

First Online: 6 March 2025

Declarations

:

: On behalf of all the authors, the corresponding authors state that there is no conflict of interest.

: Not applicable.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below